ACCP - Store - PSAP 2026 Book 3 (Pulmonary and Gastrointestinal)

PSAP 2026 Book 3 (Pulmonary and Gastrointestinal)

Format to Purchase:

Member Price:
$---.--

Nonmember Price:
$---.--

Member Price:
$88.00

Nonmember Price:
$132.00

Member Price:
$128.00

Nonmember Price:
$172.00

The optimization of pharmacotherapy for patients living with pulmonary and GI disorders requires an evidence-based, practice-focused perspective that integrates chronic care management with acute care decision-making. The latest release of ACCP’s popular Pharmacotherapy Self-Assessment Program provides these comprehensive clinical insights as well as other updates to contemporary pharmacy practice across prevalent, complex therapeutic areas.

The target audience for PSAP 2026 Book 3 (Pulmonary and Gastrointestinal Diseases) includes board-certified pharmacotherapy specialists (BCPS) and other advanced-level clinical pharmacists caring for patients across internal medicine, ambulatory care, critical care, and specialty practice settings including infectious diseases and solid organ transplant.

Pulmonary and Gastrointestinal Diseases contains nine learning activities offering a total of TBD available continuing pharmacy education (CPE) credits. Each learning activity may be taken individually for CPE credit. The book content was developed under the leadership of Paul M. Boylan, Pharm.D., BCPS.

Continuing education activities in PSAP cover the most recent published data (past 3–5 years) on a specific therapeutic area or patient-care problem. Learning content is provided as an electronic book (interactive PDF) with high-level updates in up to three formats, as appropriate to the topic:

Traditional chapters review the latest published evidence on a therapeutic or practice-related topic
In a case series feature, major sections of learning content are each bookended by a sample case and its explained answer
Recorded webcasts provide learning content as a PowerPoint presentation, accessed as an MP4 file, as well as a PDF of slides and a transcribed narrative

Every PSAP release comes in two full-color online formats: (1) interactive PDFs you can save to your desktop or print; and (2) an e-media version you can view on an e-reader, tablet, iOS, or Android smartphone. Learning elements are also available in audio format (MP3 files) through the popular PSAP Audio Companion. For an additional fee, a limited number of one-color softbound print books can be added to these formats and shipped to your address.

All PSAP chapters are fully referenced, with clickable hyperlinks to literature compilers such as PubMed. Other links provide ready access to clinical practice guidelines, official recommendations, and patient assessment tools. Graphic features focus on pivotal studies, patient care scenarios, and take-home points that can be readily integrated into clinical practice.

Publisher: ACCP, 200 pages, September 2026; ISBN-13s: 978-1-964074-40-5 (print); 978-1-964074-41-2 (eBook)

Release Date: September 15, 2026
BCPS Deadline: March 15, 2027

ACPE Deadline: September 15, 2029

MORE PRODUCTS IN THIS SERIES

Chapter: Chronic Obstructive Pulmonary Disease

Chapter: Tuberculosis

Case Series: Respiratory Syncytial Virus

Recorded Webcast: Obstructive and Central Sleep Apnea

Chapter: Gastroesophageal Reflux Disease and Peptic Ulcer Disease

Case Series: Cirrhosis Complications and Alcohol-Related Liver Disease

Case Series: Gastrointestinal Bleeding

Recorded Webcast: Enteral and Parenteral Nutrition

Case Series: Kidney, Pancreas, and Liver Transplant

Faculty

Herman J. Johannesmeyer, Pharm.D., BCPS

Faculty

Bernadette Johnson Jakeman, Pharm.D., BCPS, AAHIVP
Associate Professor University of New Mexico

Faculty

Michelle L. Patterson, Pharm.D., BCACP, CDCES

Faculty

Paul J. Solinsky, Pharm.D., BCACP, AE-C
Clinical Associate Professor of Pharmacy Practice
University of Maryland School of Pharmacy
Baltimore, Maryland
Clinical Pharmacist
Baltimore Washington Medical Center - Pulmonary Care
Glen Burnie, Maryland

Faculty

Kelly L. Covert, Pharm.D., BCPS
Associate Professor of Pharmacy Practice
East Tennessee State University Bill Gatton College of Pharmacy
Johnson City, TN

Faculty

Ashley N. Fox, Pharm.D., BCPS
Pharmacist Clinical Specialist
UCHealth Parkview Medical Center
Pueblo, Colorado

Faculty

	Philip K. King, Pharm.D., FCCP, BCPS Associate Professor of Pharmacy Practice, Butler University College of Pharmacy and Health Sciences, Indianapolis, IN; Clinical Pharmacy Specialist, Internal Medicine, Indiana University Health Methodist Hospital, Indianapolis, IN
	Lauren M. Czosnowski, Pharm.D. Associate Professor of Pharmacy Practice Butler University Indianapolis, IN

Faculty

Haley L. Kavelak, Pharm.D.
Critical Care Clinical Pharmacy Specialist St. Luke's University Health Network

Faculty

Nicole A. Pilch, Pharm.D., FAST, BCPS, BCTXP, CPHQ
Solid Organ Transplant Clinical Specialist, Medical University of South Carolina, Charleston, South Carolina

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

The American College of Clinical Pharmacy is approved by BPS as a provider for the recertification of BCPS.

BPS is an autonomous division of the American Pharmacists Association. To maintain its strict, independent standards for certification, BPS does NOT endorse or provide review information, preparatory courses, or study guides for board certification examinations. BPS, through its specialty councils, is responsible for specialty examination content, administration, scoring, and all other aspects of its certification programs. BPS is totally separate and distinct from ACCP. For information about BPS specialty recertification the BPS recertification process, go to: www.bpsweb.org/

To receive recertification credit, posttests must be submitted prior to the recertification posttest deadline (see above). Only completed tests are eligible for credit; no partial or incomplete tests will be processed. You may complete one or all available posttests for credit.

The passing point to earn recertification credit is based on an expert analysis of the assessment items in each posttest. Any posttest submitted before the recertification test deadline that meets this passing point will earn recertification credits. These credits will be assigned as of the date of test submission and reported within 48 hours to BPS. For statements of recertification credit, visit www.bpsweb.org.

In accordance with BPS guidelines concerning remediation for products launched in 2024 and after, posttests that do not reach the passing point for recertification credit will generate a second-chance test option. This test will automatically appear in the learner’s My Account page and will have assessment items presented in a different order. To qualify for recertification credit, the second-chance test must be submitted before the recertification deadline stated above.

The ACCP Recertification Dashboard is a free online tool that can track recertification credits as they are earned through ACCP and schedule new opportunities for credits from upcoming ACCP professional development programs. Questions regarding the number of hours required for recertification should be directed to BPS at www.bpsweb.org.

Target Audience: The target audience for PSAP 2026 Book 3 (Pulmonary and Gastrointestinal Diseases) includes board-certified pharmacotherapy specialists (BCPS) and other advanced-level clinical pharmacists caring for patients across internal medicine, ambulatory care, critical care, and specialty practice settings including infectious diseases and solid organ transplant.

Chapter: Chronic Obstructive Pulmonary Disease Activity Number: Contact Hour(s): Activity Type: Application Based
Chapter: Tuberculosis Activity Number: Contact Hour(s): Activity Type: Application Based
Case Series: Respiratory Syncytial Virus Activity Number: Contact Hour(s): Activity Type: Application Based
Recorded Webcast: Obstructive and Central Sleep Apnea Activity Number: Contact Hour(s): Activity Type: Application Based
Chapter: Gastroesophageal Reflux Disease and Peptic Ulcer Disease Activity Number: Contact Hour(s): Activity Type: Application Based
Case Series: Cirrhosis Complications and Alcohol-Related Liver Disease Activity Number: Contact Hour(s): Activity Type: Application Based
Case Series: Gastrointestinal Bleeding Activity Number: Contact Hour(s): Activity Type: Application Based
Recorded Webcast: Enteral and Parenteral Nutrition Activity Number: Contact Hour(s): Activity Type: Application Based
Case Series: Kidney, Pancreas, and Liver Transplant Activity Number: Contact Hour(s): Activity Type: Application Based

The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.

PSAP 2026 Book 3 (Pulmonary and Gastrointestinal)